Zobrazeno 1 - 2
of 2
pro vyhledávání: '"R.E.Y. van den Eijnde"'
Autor:
Ingrid G.M. Kolfschoten, Ruurd C. Verheul, J.C.T. van Deutekom, P.C. de Visser, Rudie Weij, A. Baghat, M.M. Plug, J.A.M. Janson, R.E.Y. van den Eijnde
Publikováno v:
Neuromuscular Disorders. 24:820-821
Antisense oligonucleotides (AONs) for Duchenne muscular dystrophy (DMD) are designed to induce skipping of a single exon during pre-mRNA splicing, thus restoring the transcript’s open reading frame and consequently synthesis of the deficient dystro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f03f7b17ad2d57d1174f0ddba3b4e0cb
https://doi.org/10.1016/j.nmd.2014.06.101
https://doi.org/10.1016/j.nmd.2014.06.101
Autor:
Ingrid G.M. Kolfschoten, J.C.T. van Deutekom, Anneke A.M. Janson, Suzanne Bijl, P.C. de Visser, R.E.Y. van den Eijnde, M.H.C. Zonneveld-Mulder
Publikováno v:
Neuromuscular Disorders. 23:803-804
In recent years, the field of antisense oligonucleotides (AONs) as RNA modulating therapeutics has made significant progress. Several antisense drug candidates are in (pre-) clinical development for Duchenne muscular dystrophy (DMD). Their length may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::100f7a9113629d2090ff3665d02b978d
https://doi.org/10.1016/j.nmd.2013.06.578
https://doi.org/10.1016/j.nmd.2013.06.578